Regenerative Patch is a pioneering brand in the field of regenerative medicine, dedicated to advancing the frontiers of clinical-stage research. With a $50 million investment from the California Institute for Regenerative Medicine (CIRM), Regenerative Patch is at the forefront of groundbreaking discoveries and innovations. Their range of products and services encompasses a wide spectrum of regenerative therapies, backed by rigorous clinical trials and cutting-edge technology.

From their Alpha Stem Cell Clinics to their Cell and Gene Therapy Center, Regenerative Patch offers state-of-the-art treatments for various diseases and conditions. The brand actively collaborates with research institutions and industry partners, fostering innovative partnerships to accelerate the development and delivery of life-changing regenerative therapies. Through their Genomics Initiative and iPSC Repository, they provide invaluable resources to researchers and clinicians, driving advancements in the field.

Regenerative Patch is committed to improving patient outcomes and transforming healthcare. Their patient resources and clinical trials offer hope and possibility to those in need. With a strong focus on education and public engagement, they are bridging the gap between science and society, raising awareness and promoting the immense potential of regenerative medicine.

Join Regenerative Patch in their mission to create a healthier future through the power of regenerative therapies